- XARELTO® may increase your chance of bleeding. This bleeding can sometimes be serious (and even life-threatening)
- In studies side effects with XARELTO® included fluid leakage from a wound, itching, pain in arms or legs, blisters, fainting, and muscle spasm
- Discuss any side effects with your doctor. You are also encouraged to report side effects to the FDA: visit http://www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to Janssen Pharmaceuticals, Inc. at 1-800-JANSSEN (526-7736)
This is a summary of important information about XARELTO®. If you would like more information, talk with your doctor.
Please see full Product Information (http://www.janssenpharmaceuticalsinc.jnj.com/assets/xareltopi.pdf), or visit www.XARELTOhcp.com.
About Janssen Pharmaceuticals, Inc.
As a member of the Janssen Pharmaceutical Companies of Johnson & Johnson, Janssen Pharmaceuticals, Inc., is dedicated to addressing and solving some of the most important unmet medical needs in pain management, infectious diseases and cardiovascular and metabolic diseases. Driven by our commitment to patients, we work together to bring innovative ideas, products, services and solutions to individuals with serious conditions, and to physicians throughout the world.
For more information on Janssen Pharmaceuticals, Inc., visit us at www.janssenpharmaceuticalsinc.com or follow us on Twitter at www.twitter.com/JanssenUS.
Dr. Kwong is a paid consultant to Jan
Page: 1 2 3 4 5 6 Related medicine technology :1
|SOURCE Janssen Pharmaceuticals, Inc.|
Copyright©2010 PR Newswire.
All rights reserved
. FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients2
. FDA Approves First Generic Versions of the Antibiotic Levofloxacin to Treat Certain Infections3
. FDA Approves Nulojix for Kidney Transplant Patients4
. FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment5
. FDA Approves First Ceramic-on-Metal Total Hip Replacement System6
. FDA Approves Redesigned Labels for Some Merck Drugs7
. FDA Approves Updates to Lillys Humalog® (insulin lispro injection [rDNA origin]) Label8
. FDA Approves Marketing of RMS Subcutaneous Needle Sets9
. FDA Approves Injectable Gel to Treat Fecal Incontinence10
. FDA approves Incivek for hepatitis C11
. FDA Approves Sutent for Rare Type of Pancreatic Cancer